Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
CD27P26842CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27)Cancer-related genesCD markersDisease related genes1Brain cancerColorectal cancerHead and neck cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.25
CD70P32970CD70 antigen (CD27 ligand) (CD27-L) (Tumor necrosis factor ligand superfamily member 7) (CD antigen CD70)1Adhesion and uptake mediationImmune mediationReceptor-signaling mediation20.25
CD79AP11912B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a)Cancer-related genesCD markersDisease related genes1Clinical-translation mediationFusion and delivery mediationImmune mediation20.25
CELR3Q9NYQ7Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2)G-protein coupled receptorsPlasma proteinsPredicted membrane proteins7Adhesion and uptake mediationReceptor-signaling mediation20.25
CL12AQ5QGZ9C-type lectin domain family 12 member A (C-type lectin-like molecule 1) (CLL-1) (Dendritic cell-associated lectin 2) (DCAL-2) (Killer cell C-type lectin-like receptor L1) (hKLRL1) (Myeloid inhibitory C-type lectin-like receptor) (MICL) (CD antigen CD371)CD markersPredicted intracellular proteinsPredicted membrane proteins1Fusion and delivery mediationImmune mediation20.25
CNR2P34972Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Clinical-translation mediationImmune mediationReceptor-signaling mediation20.25
CXL16Q9H2A7C-X-C motif chemokine 16 (Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein) (SR-PSOX) (Small-inducible cytokine B16) (Transmembrane chemokine CXCL16)Predicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins1Adhesion and uptake mediationImmune mediationReceptor-signaling mediation20.25
CY24BP04839NADPH oxidase 2 (EC 1.6.3.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Cytochrome b-245 heavy chain) (Heme-binding membrane glycoprotein gp91phox) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)Disease related genesHuman disease related genesPotential drug targets6Fusion and delivery mediationImmune mediationMetabolism mediation20.25
DRAP01903HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)Plasma proteinsPredicted membrane proteins1Adhesion and uptake mediationFusion and delivery mediationImmune mediation20.25
EMP2P54851Epithelial membrane protein 2 (EMP-2) (Protein XMP)Disease related genesHuman disease related genesPredicted membrane proteins4Adhesion and uptake mediationFusion and delivery mediationImmune mediation20.25
EPHB4P54760Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)Cancer-related genesDisease related genesEnzymes1Brain cancerCystic/dysplastic kidney diseaseLung cancerClinical-translation mediationReceptor-signaling mediation20.25
GBRB3P28472Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3)4Fusion and delivery mediationReceptor-signaling mediation20.25
GP176Q14439G-protein coupled receptor 176 (HB-954)G-protein coupled receptorsPredicted membrane proteins7Receptor-signaling mediation20.25
GRIK3Q13003Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)3Fusion and delivery mediationReceptor-signaling mediation20.25
GTR9Q9NRM0Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9) (Urate transporter)Disease related genesHuman disease related genesMetabolic proteins12Clinical-translation mediationFusion and delivery mediation20.25
ICAM5Q9UMF0Intercellular adhesion molecule 5 (ICAM-5) (Telencephalin)Plasma proteinsPredicted membrane proteins1Immune mediation20.25
INAR1P17181Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1)Cancer-related genesDisease related genesFDA approved drug targets1Hepatitis virus infectionOvarian cancerClinical-translation mediationFusion and delivery mediationImmune mediation20.25
KI3L1P43629Killer cell immunoglobulin-like receptor 3DL1 (CD158 antigen-like family member E) (HLA-BW4-specific inhibitory NK cell receptor) (Natural killer-associated transcript 3) (NKAT-3) (p70 natural killer cell receptor clones CL-2/CL-11) (p70 NK receptor CL-2/CL-11) (CD antigen CD158e)1Immune mediation20.25
LMBD1Q9NUN5Lysosomal cobalamin transport escort protein LMBD1 (LMBD1) (HDAg-L-interacting protein NESI) (LMBR1 domain-containing protein 1) (Nuclear export signal-interacting protein)Disease related genesHuman disease related genesPotential drug targets9Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.25
LMBD2Q68DH5G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2)Disease related genesPotential drug targetsPredicted membrane proteins9Receptor-signaling mediation20.25
LRC8BQ6P9F7Volume-regulated anion channel subunit LRRC8B (Leucine-rich repeat-containing protein 8B) (T-cell activation leucine repeat-rich protein) (TA-LRRP)Predicted membrane proteinsTransporters4Fusion and delivery mediation20.25
NLGNXQ8N0W4Neuroligin-4, X-linked (Neuroligin X) (HNLX)Disease related genesHuman disease related genesPotential drug targets1Fusion and delivery mediation20.25
NOTC1P46531Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]Cancer-related genesDisease related genesHuman disease related genes1LymphomaMature T-cell lymphomaSolid tumour/cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.25
P2RX1P51575P2X purinoceptor 1 (P2X1) (ATP receptor) (Purinergic receptor)2Fusion and delivery mediationImmune mediationMetabolism mediation20.25
PCD19Q8TAB3Protocadherin-19Disease related genesHuman disease related genesPredicted intracellular proteins1Adhesion and uptake mediation20.25

976-1,000 of 1,200 proteins

Page